Cimpress plc [CMPR] vs Acuren [TIC] Detailed Stock Comparison
Cimpress plc
NASDAQ
Loading...
Acuren
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Cimpress plc wins in 14 metrics, Acuren wins in 2 metrics, with 0 ties. Cimpress plc appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Cimpress plc | Acuren | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 101.57 | 44.48 | Acuren |
| Price-to-Book Ratio | N/A | 1.03 | N/A |
| Debt-to-Equity Ratio | -3.03 | 68.97 | Cimpress plc |
| PEG Ratio | 10.46 | N/A | N/A |
| EV/EBITDA | 9.48 | 32.48 | Cimpress plc |
| Profit Margin (TTM) | 0.44% | -12.62% | Cimpress plc |
| Operating Margin (TTM) | 8.08% | 6.01% | Cimpress plc |
| EBITDA Margin (TTM) | 8.08% | 6.01% | Cimpress plc |
| Return on Equity | -2.65% | -18.02% | Cimpress plc |
| Return on Assets (TTM) | 7.51% | -1.05% | Cimpress plc |
| Free Cash Flow (TTM) | $144.95M | $73.67M | Cimpress plc |
| 1-Year Return | -36.12% | -18.73% | Acuren |
| Price-to-Sales Ratio (TTM) | 0.42 | 1.79 | Cimpress plc |
| Enterprise Value | $2.94B | $2.69B | Cimpress plc |
| EV/Revenue Ratio | 0.86 | 2.42 | Cimpress plc |
| Gross Profit Margin (TTM) | 47.48% | 23.60% | Cimpress plc |
| Revenue per Share (TTM) | $137 | $10 | Cimpress plc |
| Earnings per Share (Diluted) | $0.58 | $-1.25 | Cimpress plc |
| Beta (Stock Volatility) | 1.70 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Cimpress plc vs Acuren Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Cimpress plc | -1.54% | -2.11% | 31.89% | 37.53% | 18.35% | -15.96% |
| Acuren | 1.99% | 7.90% | -11.65% | -4.66% | -18.73% | -14.67% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Cimpress plc | -36.12% | 62.32% | -38.07% | -19.83% | 92.07% | 286.16% |
| Acuren | -18.73% | -18.73% | 272.36% | -99.92% | -99.87% | -99.87% |
Performance & Financial Health Analysis: Cimpress plc vs Acuren
| Metric | CMPR | TIC |
|---|---|---|
| Market Information | ||
| Market Cap | $1.44B | $2.00B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 202,751 | 2,819,490 |
| 90 Day Avg. Volume | 246,390 | 2,490,210 |
| Last Close | $58.89 | $10.24 |
| 52 Week Range | $35.21 - $102.22 | $8.76 - $14.28 |
| % from 52W High | -42.39% | -28.29% |
| All-Time High | $171.76 (Mar 05, 2018) | $14,700.00 (Jul 03, 2017) |
| % from All-Time High | -65.71% | -99.93% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | 0.02% |
| Quarterly Earnings Growth | 0.04% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | -0.13% |
| Operating Margin (TTM) | 0.08% | 0.06% |
| Return on Equity (TTM) | -0.03% | -0.18% |
| Debt to Equity (MRQ) | -3.03 | 68.97 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-23.84 | $9.63 |
| Cash per Share (MRQ) | $9.56 | $0.65 |
| Operating Cash Flow (TTM) | $298.07M | $58.13M |
| Levered Free Cash Flow (TTM) | $195.70M | $127.12M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Cimpress plc vs Acuren
| Metric | CMPR | TIC |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 101.57 | 44.48 |
| Forward P/E | 10.46 | 22.54 |
| PEG Ratio | 10.46 | N/A |
| Price to Sales (TTM) | 0.42 | 1.79 |
| Price to Book (MRQ) | N/A | 1.03 |
| Market Capitalization | ||
| Market Capitalization | $1.44B | $2.00B |
| Enterprise Value | $2.94B | $2.69B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.86 | 2.42 |
| Enterprise to EBITDA | 9.48 | 32.48 |
| Risk & Other Metrics | ||
| Beta | 1.70 | N/A |
| Book Value per Share (MRQ) | $-23.84 | $9.63 |
Financial Statements Comparison: Cimpress plc vs Acuren
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CMPR | TIC |
|---|---|---|
| Revenue/Sales | $869.48M | $234.22M |
| Cost of Goods Sold | $456.68M | $190.55M |
| Gross Profit | $412.80M | $43.67M |
| Research & Development | $86.18M | N/A |
| Operating Income (EBIT) | $70.24M | $-8.79M |
| EBITDA | $106.04M | $20.93M |
| Pre-Tax Income | $13.46M | $-24.33M |
| Income Tax | $41.82M | $1.47M |
| Net Income (Profit) | $-28.36M | $-25.79M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CMPR | TIC |
|---|---|---|
| Cash & Equivalents | $233.98M | $155.74M |
| Total Current Assets | $502.61M | $376.67M |
| Total Current Liabilities | $758.66M | $107.93M |
| Long-Term Debt | $1.67B | $784.25M |
| Total Shareholders Equity | $-563.45M | $1.13B |
| Retained Earnings | $225.12M | $-132.78M |
| Property, Plant & Equipment | $83.95M | $30.52M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CMPR | TIC |
|---|---|---|
| Operating Cash Flow | $75.23M | $35.09M |
| Capital Expenditures | $-20.81M | $-4.18M |
| Free Cash Flow | $70.16M | $28.32M |
| Debt Repayment | $-6.18M | $-4.44M |
| Common Stock Repurchase | $-20.84M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CMPR | TIC |
|---|---|---|
| Shares Short | 1.94M | 12.04M |
| Short Ratio | 6.31 | 9.17 |
| Short % of Float | 0.14% | 0.23% |
| Average Daily Volume (10 Day) | 202,751 | 2,819,490 |
| Average Daily Volume (90 Day) | 246,390 | 2,490,210 |
| Shares Outstanding | 24.48M | 121.48M |
| Float Shares | 14.30M | 138.35M |
| % Held by Insiders | 0.17% | 0.10% |
| % Held by Institutions | 0.85% | 0.52% |
Dividend Analysis & Yield Comparison: Cimpress plc vs Acuren
| Metric | CMPR | TIC |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |